Oklahoma 2025 2025 Regular Session

Oklahoma House Bill HB1389 Amended / Bill

Filed 03/07/2025

                     
 
HB1389 HFLR 	Page 1 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
HOUSE OF REPRESENTATIVES - FLOOR VERSION 
 
STATE OF OKLAHOMA 
 
1st Session of the 60th Legislature (2025) 
 
COMMITTEE SUBSTITUTE 
FOR 
HOUSE BILL NO. 1389 	By: Provenzano and Roe of the 
House 
 
   and 
 
  Stanley of the Senate 
 
 
 
 
COMMITTEE SUBSTITUTE 
 
An Act relating to mammography screening; amending 36 
O.S. 2021, Section 6060, as amended by Section 1, 
Chapter 294, O.S.L. 2022 (36 O.S. Supp. 2024, Section 
6060), which relates to coverage for low -dose 
mammography screening; adding new types of 
examinations; adding a definition; and providing an 
effective date. 
 
 
 
 
 
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA: 
SECTION 1.     AMENDATORY     36 O.S. 2021, Section 6060, as 
amended by Section 1, Chapter 294, O.S.L. 2022 (36 O. S. Supp. 2024, 
Section 6060), is amended to read as follows: 
Section 6060.  A.  For the purposes of this section: 
1.  "Breast magnetic resonance imaging" means a diagnostic tool 
used to produce detailed pictures of the structure of the breast;   
 
HB1389 HFLR 	Page 2 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
2.  "Breast ultrasound" means a noninvasive, diagnostic imaging 
technique that uses high -frequency sound waves to produce detailed 
images of the breast; 
3.  "Diagnostic examination for breast cancer" means a medically 
necessary and clinically appropriate examination, as defined by 
current guidelines and as determined by a clinician who is 
evaluating the individual for breast cancer, to evaluate the 
abnormality in the breast that is: 
a. seen or suspected from a screening examination for 
breast cancer, 
b. detected by another means of examination, or 
c. suspected based on the medical history or family 
medical history of the individual. 
This examination may include, but is not limited to, a contrast–
enhanced mammogram, diagnostic mammogram, breast magnetic resonance 
imaging, or a breast ultrasound, or molecular breast imaging ; 
4.  "Diagnostic mammography" means a diagnostic tool that: 
a. uses X-ray, and 
b. is designed to evaluate abnormality in a breast; 
5.  "Health benefit plan" means any plan or arrangement as 
defined in subsection C of Section 6060.4 of this title; 
6.  "Low-dose mammography" means: 
a. the X-ray examination of the breast using equipment 
specifically dedicated for such purpose, with an   
 
HB1389 HFLR 	Page 3 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
average radiation exposure delivery of less than one 
rad mid-breast and with two views for each breast, 
b. digital mammography, or 
c. breast tomosynthesis; 
7.  "Breast tomosynthesis" means a radiologic mammography 
procedure involving the acquisition of projection images over a 
stationary breast to produce cross -sectional digital three-
dimensional images of the breast from which breast cancer screening 
diagnoses may be made; and 
8.  "Screening mammography" means a radiologic procedure 
provided to a woman, who has no signs or symptoms of breast cancer, 
for the purpose of early det ection of breast cancer, including 
breast tomosynthesis ; and 
9.  "Supplemental examinations" means a medically necessary and 
appropriate examination of the breast, including, but not limited 
to, such an examination using contrast –enhanced mammography, brea st 
magnetic resonance imaging, breast ultrasound, or molecular breast 
imaging that is: 
a. used to screen for breast cancer when there is no 
abnormality seen or suspected, and 
b. based on personal or family medical history or 
additional factors that increas e the individual's risk 
of breast cancer, including heterogeneously or 
extremely dense breasts .   
 
HB1389 HFLR 	Page 4 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
B.  All health benefit plans shall include the coverage 
specified by this section for a low -dose mammography screening for 
the presence of occult breast cancer and a diagnostic and 
supplemental examination for breast cancer.  Such coverage shall 
not: 
1.  Be subject to the policy deductible, co -payments and co-
insurance limits of the plan; or 
2.  Require that a female undergo a mammography screening at a 
specified time as a condition of payment. 
C.  1.  Any female thirty -five (35) through thirty -nine (39) 
years of age shall be entitled pursuant to the provisions of this 
section to coverage for a low -dose mammography screening once every 
five (5) years. 
2.  Any female forty (40) years of age or older shall be 
entitled pursuant to the provisions of this section to coverage for 
an annual low-dose mammography screening. 
D.  If application of this act would result in health savings 
account ineligibility under Section 223 of the federal Internal 
Revenue Code, as amended, the provisions of this section shall only 
apply to health savings accounts with qualified high deductible 
health plans with respect to the deductible of such a plan after the 
enrollee has satisfied the min imum deductible.  Provided, however, 
the provisions of this section shall apply to items of services that 
are preventive care pursuant to Section 223(c)(2)(c) of the federal   
 
HB1389 HFLR 	Page 5 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
Internal Revenue Code, as amended, regardless of whether the minimum 
deductible has been satisfied. 
SECTION 2.  This act shall become effective November 1, 2025. 
 
COMMITTEE REPORT BY: COMMITTEE ON HEALTH AND HUMAN SERVICES 
OVERSIGHT, dated 03/05/2025 - DO PASS, As Amended.